Role of Somatostatin and Somatostatin Receptors in Pain

Peripheral Receptor Targets for Analgesia: Novel Approaches to Pain Management

Volumn , Issue , 2009, Pages 397-417

  Kumar, Ujendra ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Somatostatin and somatostatin receptors in pain; SST and SSTRs expression in pain regulatory pathway; SSTR signaling and G protein activation

Indexed keywords

EID: 80052244879     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470522226.ch16     Document Type: Chapter

References (127)

1. Brazeau, P., Vale, W., Burgus, R., Ling, N., Butcher, M., Rivier, J., Guillemin, R. (1973). Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone. Science 179: 77-79.
2. Lamberts, S.W., van der Lely, A.J., de Herder, W.W., Hofland, L.J. (1996). Somatostatin analogs: future directions. Metabolism 45: 104-106.
3. Patel, Y.C. (1997). Molecular pharmacology of somatostatin receptor subtypes. J Endocrinol Invest 20: 348-367.
4. Epelbaum, J., Tapia Arancibia, L., Kordon, C., Enjalbert, A. (1982). Characterization, regional distribution, and subcellular distribution of 125I-Tyr1-somatostatin binding sites in rat brain. J Neurochem 38: 1515-1523.
5. Tran, V.T., Uhl, G.R., Perry, D.C., Manning, D.C., Vale, W.W., Perrin, M.H., Rivier, J.E., Martin, J.B., Snyder, S.H. (1984). Autoradiographic localization of somatostatin receptors in rat brain. Eur J Pharmacol 101: 307-309.
6. Leroux, P., Quirion, R., Pelletier, G. (1985). Localization and characterization of brain somatostatin receptors as studied with somatostatin-14 and somatostatin-28 receptor radioautography. Brain Res 347: 74-84.
7. Reubi, J.C., Maurer, R. (1985). Autoradiographic mapping of somatostatin receptors in the rat central nervous system and pituitary. Neuroscience 15: 1183-1193.
8. Uhl, G.R., Tran, V., Snyder, S.H., Martin, J.B. (1985). Somatostatin receptors: distribution in rat central nervous system and human frontal cortex. J Comp Neurol 240: 288-304.
9. Raynor, K., Reisine, T. (1989). Analogs of somatostatin selectively label distinct subtypes of somatostatin receptors in rat brain. J Pharmacol Exp Ther 251: 510-517.
10. Krantic, S., Martel, J.C., Weissmann, D., Pujol, J.F., Quirion, R. (1990). Quantitative radioautographic study of somatostatin receptors heterogeneity in the rat extrahypothalamic brain. Neuroscience 39: 127-137.
11. Martin, J.L., Chesselet, M.F., Raynor, K., Gonzales, C., Reisine, T. (1991). Differential distribution of somatostatin receptor subtypes in rat brain revealed by newly developed somatostatin analogs. Neuroscience 41: 581-593.
12. Dournaud, P., Boudin, H., Schonbrunn, A., Tannenbaum, G.S., Beaudet, A. (1998). Interrelationships between somatostatin sst2A receptors and somatostatin - containing axons in rat brain: evidence for regulation of cell surface receptors by endogenous somatostatin. J Neurosci 18 (3): 1056-1071.
13. Schindler, M., Sellers, L.A., Humphrey, P.P., Emson, P.C. (1997). Immunohistochemical localization of the somatostatin SST2(A) receptor in the rat brain and spinal cord. Neuroscience 76: 225-240.
14. Helboe, L., Stidsen, C.E., Moller, M. (1998). Immunohistochemical and cytochemical localization of the somatostatin receptor subtype sst1 in the somatostatinergic parvocellular neuronal system of the rat hypothalamus. J Neurosci 18: 4938-4945.
15. Hervieu, G., Emson, P.C. (1998). The localization of somatostatin receptor 1 (sst1) immunoreactivity in the rat brain using an N-terminal specific antibody. Neuroscience 85: 1263-1284.
16. Handel, M., Schulz, S., Stanarius, A., Schreff, M., Erdtmann-Vourliotis, M., Schmidt, H., Wolf, G., Hollt, V. (1999). Selective targeting of somatostatin receptor 3 to neuronal cilia. Neuroscience 89: 909-926.
17. Helboe, L., Hay-Schmidt, A., Stidsen, C.E., Moller, M. (1999). Immunohistochemical localization of the somatostatin receptor subtype 2 (sst2). in the central nervous system of the golden hamster (Mesocricetus auratus). J Comp Neurol 405: 247 - 261.
18. Schindler, M., Humphrey, P.P., Lohrke, S., Friauf, E. (1999). Immunohistochemical localization of the somatostatin sst2 (b) receptor splice variant in the rat central nervous system. Neuroscience 90: 859-874.
19. Stroh, T., Kreienkamp, H.J., Beaudet, A. (1999). Immunohistochemical distribution of the somatostatin receptor subtype 5 in the adult rat brain: predominant expression in the basal forebrain. J Comp Neurol 412: 69-82.
20. Selmer, I.S., Schindler, M., Humphrey, P.P., Emson, P.C. (2000). Immunohistochemical localization of the somatostatin sst(4) receptor in rat brain. Neuroscience 98: 523-533.
21. Schreff, M., Schulz, S., Handel, M., Keilhoff, G., Braun, H., Pereira, G., Klutzny, M., Schmidt, H., Wolf, G., Hollt, V. (2000). Distribution, targeting, and internalization of the sst4 somatostatin receptor in rat brain. J Neurosci 20: 3785-3797.
22. Schulz, S., Handel, M., Schreff, M., Schmidt, H., Hollt, V. (2000). Localization of five somatostatin receptors in the rat central nervous system using subtype - specific antibodies. J Physiol (Paris) 94: 259-264.
23. Kumar, U. (2005). Expression of somatostatin receptor subtypes (SSTR1-5) in Alzheimer' s disease brain: an immunohistochemical analysis. Neuroscience 134: 525-538.
24. Stroh, T., Sarret, P., Tannenbaum, G.S., Beaudet, A. (2006). Immunohistochemical distribution and subcellular localization of the somatostatin receptor subtype 1 (sst1) in the rat hypothalamus. Neurochem Res 31: 247-257.
25. Kumar, U. (2007). Colocalization of somatostatin receptor subtypes (SSTR1-5) with somatostatin, NADPH-diaphorase (NADPH-d), and tyrosine hydroxylase in the rat hypothalamus. J Comp Neurol 504: 185-205.
26. Patel, Y.C., Srikant, C.B. (1997). Somatostatin receptors. Trends Endocrinol Metab 8: 398-405.
27. Mouchantaf, R., Kumar, U., Sulea, T., Patel, Y.C. (2001). A conserved ?-helix at the amino terminal segment of prosomatostatin serves as a sorting signal for the regulated secretory pathway. J Biol Chem 276: 26308-26316.
28. Patel, Y.C., Galanopoulou, A.S., Rabbani, S.N., Liu, J.L., Ravazzola, M., Amherdt, M. (1997). Somatostatin-14, somatostatin-28, and prosomatostatin[1-10] are independently and efficiently processed from prosomatostatin in the constitutive secretory pathway in islet somatostatin tumor cells (1027B2). Mol Cell Endocrinol 131: 183-194.
29. Mouchantaf, R., Watt, H.L., Suela, T., Seidah, N.G., Alturaihi, H., Patel, Y.C., Kumar, U. (2004). Prosomatostatin is proteolytically processed at the amino terminal segment by subtilase SKI-1. Regul Pept 120: 133-140.
30. Elekes, K., Helyes, Z., Kereskai, L., Sandor, K., Pinter, E., Pozsgai, G., Tekus, V., Banvolgyi, A., Nemeth, J., Szuts, T., Keri, G., Szolcsanyi, J. (2008). Inhibitory effects of synthetic somatostatin receptor subtype 4 agonists on acute and chronic airway inflammation and hyperreactivity in the mouse. Eur J Pharmacol 578: 313-322.
31. Bar, K.J., Schurigt, U., Scholze, A., Segond Von Banchet, G., Stopfel, N., Brauer, R., Halbhuber, K.J., Schaible, H.G. (2004). The expression and localization of somatostatin receptors in dorsal root ganglion neurons of normal and monoarthritic rats. Neuroscience 127: 197-206.
32. Carlton, S.M., Zhou, S., Du, J., Hargett, G.L., Ji, G., Coggeshall, R.E. (2004). Somatostatin modulates the transient receptor potential vanilloid 1 (TRPV1) ion channel. Pain 110: 616-627.
33. Hokfelt, T., Elde, R., Johansson, O., Luft, R., Nilsson, G., Arimura, A. (1976). Immunohistochemical evidence for separate populations of somatostatin - containing and substance P-containing primary afferent neurons in the rat. Neuroscience 1: 131-136.
34. Tessler, A., Himes, B.T., Gruber-Bollinger, J., Reichlin, S. (1986). Characterization of forms of immunoreactive somatostatin in sensory neuron and normal and deafferented spinal cord. Brain Res 370: 232-240.
35. Pan, H.L., Wu, Z.Z., Zhou, H.Y., Chen, S.R., Zhang, H.M., Li, D.P. (2008). Modulation of pain transmission by G-protein-coupled receptors. Pharmacol Ther 117: 141-161.
36. Dournaud, P., Gum, Y.Z., Schonbrunn, A., Mazella, J., Tannenbaum, G.S., Beaudet, A. (1996). Localization of the somatostatin receptor SST2A in rat brain using a specific anti-peptide antibody. J Neurosci 16 (14): 4468-4478.
37. Hervieu, G., Emson, P.C. (1998). The localization of somatostatin receptor 1 (sst1) immunoreactivity in the rat brain using an N-terminal specific antibody. Neuroscience 85: 1263-1284.
38. Hervieu, G., Emson, P.C. (1999). Visualisation of somatostatin receptor sst(3) in the rat central nervous system. Brain Res Mol Brain Res 71 (2): 290-303.
39. Selmer, I.S., Schindler, M., Humphrey, P.P., Emson, P.C. (2000). Immunohistochemical localization of the somatostatin sst(4) receptor in rat brain. Neuroscience 98 (3): 523-233.
40. Stroh, T., Kreienkamp, H.J., Beaudet, A. (1999). Immunohistochemical distribution of the somatostatin receptor subtype 5 in the adult rat brain: predominant expression in the basal forebrain. J Comp Neurol 412 (1): 69-82.
41. Schonbrunn, A., Tashjian, H., Jr. (1978). Characterization of functional receptors for somatostatin in rat pituitary cells in culture. J Biol Chem 253: 6473-6483.
42. Yamada, Y., Post, S.R., Wang, K., Tager, H.S., Bell, G.I., Seino, S. (1992). Cloning and functional characterization of a family of human and mouse somatostatin receptors expressed in brain, gastrointestinal tract, and kidney. Proc Natl Acad Sci U S A 89: 251-255.
43. Patel, Y.C., Greenwood, M.T., Panetta, R., Demchyshyn, L., Niznik, H. Srikant, C.B. (1995). The somatostatin receptor family. Life Sci 57: 1249-1265.
44. Patel, Y.C., Greenwood, M., Panetta, R., Hukovic, N., Grigorakis, S., Robertson, L.A., Srikant, C.B. (1996). Molecular biology of somatostatin receptor subtypes. Metabolism 45: 31-38.
45. Patel, Y.C. (1999). Somatostatin and its receptor family. Front Neuroendocrinol 20: 157-198.
46. Sharma, K., Patel, Y.C., Srikant, C.B. (1999). C-terminal region of human somatostatin receptor 5 is required for induction of Rb and G1 cell cycle arrest. Mol Endocrinol 13: 82-90.
47. Kreienkamp, H.J., Liew, C.W., Bachner, D., Mameza, M.G., Soltau, M., Quitsch, A., Christenn, M., Wente, W., Richter, D. (2004). Physiology of somatostatin receptors: From genetics to molecular analysis. In: Srikant, C.B. (ed.)., Somatostatin. Norwell, MA: Kluwer Academic Publishers, pp. 185-202.
48. Liapakis, G., Hoeger, C., Rivier, J., Reisine, T. (1996). Development of a selective agonist at the somatostatin receptor subtype sstr1. J Pharmacol Exp Ther 276: 1089-1094.
49. Bruns, C., Lewis, I., Briner, U., Meno-Tetang, G., Weckbecker, G. (2002). SOM230: a novel somatostatin peptidomimetic with broad somatotropin release inhibiting factor (SRIF) receptor binding and a unique antisecretory profile. Eur J Endocrinol 146: 707-716.
50. Weckbecker, G., Briner, U., Lewis, I., Bruns, C. (2002). SOM230: a new somatostatin peptidomimetic with potent inhibitory effects on the growth hormone/insulin - like growth factor-I axis in rats, primates, and dogs. Endocrinology 143: 4123-4130.
51. Labeur, M., Theodoropoulou, M., Sievers, C., Paez-Pereda, M., Castillo, V., Arzt, E., Stalla, G.K. (2006). New aspects in the diagnosis and treatment of Cushing disease. Front Horm Res 35: 169-178.
52. Weckbecker, G., Lewis, I., Albert, R., Schmid, H.A., Hoyer, D., Bruns, C. (2003). Opportunities in somatostatin research: biological, chemical and therapeutic aspects. Nat Rev Drug Discov 2: 999-1017.
53. Rohrer, S.P., Birzin, E.T., Mosley, R.T., Berk, S.C., Hutchins, S.M., Shen, D.M., Xiong, Y., Hayes, E.C., Parmar, R.M., Foor, F., Mitra, S.W., Degrado, S.J., Shu, M., Klopp, J.M., Cai, S.J., Blake, A., Chan, W.W., Pasternak, A., Yang, L., Patchett, A.A., Smith, R.G., Chapman, K.T., Schaeffer, J.M. (1998). Rapid identification of subtype-selective agonists of the somatostatin receptor through combinatorial chemistry. Science 282: 737-740.
54. Helyes, Z., Szabo, A., Nemeth, J., Jakab, B., Pinter, E., Banvolgyi, A., Kereskai, L., Keri, G., Szolcsanyi, J. (2004). Antiinflammatory and analgesic effects of somatostatin released from capsaicin-sensitive sensory nerve terminals in a Freund' s adjuvant-induced chronic arthritis model in the rat. Arthritis Rheum 50: 1677-1685.
55. Than, M., Nemeth, J., Szilvassy, Z., Pinter, E., Helyes, Z., Szolcsanyi, J. (2000). Systemic anti-inflammatory effect of somatostatin released from capsaicin - sensitive vagal and sciatic sensory fibres of the rat and guinea-pig. Eur J Pharmacol 399: 251-258.
56. Szolcsanyi, J., Bolcskei, K., Szabo, A., Pinter, E., Petho, G., Elekes, K., Borzsei, R., Almasi, R., Szuts, T., Keri, G., Helyes, Z. (2004). Analgesic effect of TT-232, a heptapeptide somatostatin analogue, in acute pain models of the rat and the mouse and in streptozotocin-induced diabetic mechanical allodynia. Eur J Pharmacol 498: 103-109.
57. S á ndor, K., Elekes, K., Szab ó, A., Pint é r, E., Engstr ö m, M., Wurster, S., Szolcs á nyi, J., Helyes Z. (2006). Analgesic effects of the somatostatin sst4 receptor selective agonist J-2156 in acute and chronic pain models. Eur J Pharmacol 539 (1-2): 71-75.
58. Bass, R.T., Buckwalter, B.L., Patel, B.P., Pausch, M.H., Price, L.A., Strnad, J., Hadcock, J.R. (1996). Identification and characterization of novel somatostatin antagonists. Mol Pharmacol 50: 709-715.
59. Feniuk, W., Jarvie, E., Luo, J., Humphrey, P.P. (2000). Selective somatostatin sst(2) receptor blockade with the novel cyclic octapeptide, CYN-154806. Neuropharmacology 39: 1443-1450.
60. Nunn, C., Langenegger, D., Hurth, K., Schmidt, K., Fehlmann, D., Hoyer, D. (2003). Agonist properties of putative small-molecule somatostatin sst2 receptor-selective antagonists. Eur J Pharmacol 465: 211-218.
61. Tulipano, G., Soldi, D., Bagnasco, M., Culler, M.D., Taylor, J.E., Cocchi, D., Giustina, A. (2002). Characterization of new selective somatostatin receptor subtype-2 (sst2) antagonists, BIM-23627 and BIM-23454. Effects of BIM-23627 on GH release in anesthetized male rats after short-term high-dose dexamethasone treatment . Endocrinology 143: 1218-1224.
62. Poitout, L., Roubert, P., Contour-Galcera, M.O., Moinet, C., Lannoy, J., Pommier, J., Plas, P., Bigg, D., Thurieau, C. (2001). Identification of potent non-peptide somatostatin antagonists with sst(3) selectivity. J Med Chem 44: 2990-3000.
63. Hoyer, D., Nunn, C., Hannon, J., Schoeffter, P., Feuerbach, D., Schuepbach, E., Langenegger, D., Bouhelal, R., Hurth, K., Neumann, P., Troxler, T., Pfaeffli, P. (2004). SRA880, in vitro characterization of the first non-peptide somatostatin sst(1) receptor antagonist. Neurosci Lett 361: 132-135.
64. Barnett, P. (2003). Somatostatin and somatostatin receptor physiology. Endocrine 20: 255-264.
65. Moller, L.N., Stidsen, C.E., Hartmann, B., Holst, J.J. (2003). Somatostatin receptors. Biochim Biophys Acta 1616: 1-84.
66. Olias, G., Viollet, C., Kusserow, H., Epelbaum, J., Meyerhof, W. (2004). Regulation and function of somatostatin receptors. J Neurochem 89: 1057-1091.
67. Patel, Y.C., Liu, J.L., Galanopoulou, A.S., Papachristou, D.N. (1999). Production, action, and degradation of somatostatin. In: Jefferson, L.S., Cherrington, A.D. (eds.). The Handbook of Physiology, The Endocrine Pancreas and Regulation of Metabolism. New York: Oxford University Press, pp. 267-302.
68. Patel, Y.C., Greenwood, M.T., Warszynska, A., Panetta, R., Srikant, C.B. (1994). All five cloned human somatostatin receptors (hSSTR1-5) are functionally coupled to adenylyl cyclase. Biochem Biophys Res Commun 198: 605-612.
69. Meyerhof, W. (1998). The elucidation of somatostatin receptor functions: a current view. Rev Physiol Biochem Pharmacol 133: 55-108.
70. Gu, Y.Z., Schonbrunn, A. (1997). Coupling specificity between somatostatin receptor sst2A and G proteins: isolation of the receptor-G protein complex with a receptor antibody. Mol Endocrinol 11: 527-537.
71. Liu, Y.F., Jakobs, K.H., Rasenick, M.M., Albert, P.R. (1994). G protein specificity in receptor-effector coupling. Analysis of the roles of G0 and Gi2 in GH4C1 pituitary cells. J Biol Chem 269: 13880-13886.
72. Tallent, M., Reisine, T. (1992). Gi alpha 1 selectively couples somatostatin receptors to adenylyl cyclase in pituitary-derived AtT-20 cells. Mol Pharmacol 41: 452-455.
73. Akopian, A., Johnson, J., Gabriel, R., Brecha, N., Witkovsky, P. (2000). Somatostatin modulates voltage-gated K(+) and Ca(2+) currents in rod and cone photoreceptors of the salamander retina. J Neurosci 20: 929-936.
74. Takano, K., Yasufuku-Takano, J., Teramoto, A., Fujita, T. (1997). Gi3 mediates somatostatin-induced activation of an inwardly rectifying K + current in human growth hormone-secreting adenoma cells. Endocrinology 138: 2405-2409.
75. Ikeda, S.R., Schofield, G.G. (1989). Somatostatin blocks a calcium current in rat sympathetic ganglion neurones. J Physiol 409: 221-240.
76. Kleuss, C., Hescheler, J., Ewel, C., Rosenthal, W., Schultz, G., Wittig, B. (1991). Assignment of G-protein subtypes to specific receptors inducing inhibition of calcium currents. Nature 353: 43-48.
77. Meriney, S.D., Gray, D.B., Pilar, G.R. (1994). Somatostatin-induced inhibition of neuronal Ca 2+ current modulated by cGMP-dependent protein kinase. Nature 369: 336-339.
78. Lin, C.Y., Varma, M.G., Joubel, A., Madabushi, S., Lichtarge, O., Barber, D.L. (2003). Conserved motifs in somatostatin, D2-dopamine, and alpha 2B-adrenergic receptors for inhibiting the Na-H exchanger, NHE1. J Biol Chem 278: 15128 - 15135.
79. Smalley, K.S., Feniuk, W., Humphrey, P.P. (1998). Differential agonist activity of somatostatin and L-362855 at human recombinant sst4 receptors. Br J Pharmacol 125: 833-841.
80. Ye, W.Z., Mathieu, S., Marteau, C. (1999). Somatostatin inhibits the Na + /H + exchange activity of rat hepatocytes in short term primary culture. Cell Mol Biol (Noisy-le-grand) 45: 1183-1189.
81. Putney, L.K., Denker, S.P., Barber, D.L. (2002). The changing face of the Na + /H + exchanger, NHE1: structure, regulation, and cellular actions. Annu Rev Pharmacol Toxicol 42: 527-552.
82. Hou, C., Gilbert, R.L., Barber, D.L. (1994). Subtype-specific signaling mechanisms of somatostatin receptors SSTR1 and SSTR2. J Biol Chem 269: 10357-10362.
83. Csaba, Z., Dournaud, P. (2001a). Cellular biology of somatostatin receptors. Neuropeptides 35: 1-23.
84. Srikant, C.B., Shen, S.H. (1996). Octapeptide somatostatin analog SMS 201-995 induces translocation of intracellular PTP1C to membranes in MCF-7 human breast adenocarcinoma cells. Endocrinology 137: 3461-3468.
85. Hortala, M., Ferjoux, G., Estival, A., Bertrand, C., Schulz, S., Pradayrol, L., Susini, C., Clemente, F. (2003). Inhibitory role of the somatostatin receptor SST2 on the intracrine-regulated cell proliferation induced by the 210-amino acid fibroblast growth factor-2 isoform: implication of JAK2. J Biol Chem 278: 20574-20581.
86. Lopez, F., Esteve, J.P., Buscail, L., Delesque, N., Saint-Laurent, N., Theveniau, M., Nahmias, C., Vaysse, N., Susini, C. (1997). The tyrosine phosphatase SHP-1 associates with the sst2 somatostatin receptor and is an essential component of sst2 - mediated inhibitory growth signaling. J Biol Chem 272: 24448-24454.
87. Ferjoux, G., Lopez, F., Esteve, J.P., Ferrand, A., Vivier, E., Vely, F., Saint-Laurent, N., Pradayrol, L., Buscail, L., Susini, C. (2003). Critical role of Src and SHP-2 in sst2 somatostatin receptor-mediated activation of SHP-1 and inhibition of cell proliferation. Mol Biol Cell 14: 3911-3928.
88. Gromada, J., Hoy, M., Buschard, K., Salehi, A., Rorsman, P. (2001). Somatostatin inhibits exocytosis in rat pancreatic alpha-cells by G(i2).-dependent activation of calcineurin and depriming of secretory granules. J Physiol 535: 519-532.
89. Bousquet, C., Puente, E., Buscail, L., Vaysse, N., Susini, C. (2001). Antiproliferative effect of somatostatin and analogs. Chemotherapy 47 (Suppl. 2): 30-39.
90. Florio, T., Yao, H., Carey, K.D., Dillon, T.J., Stork, P.J. (1999). Somatostatin activation of mitogen-activated protein kinase via somatostatin receptor 1 (SSTR1).. Mol Endocrinol 13: 24-37.
91. Lahlou, H., Saint-Laurent, N., Esteve, J.P., Eychene, A., Pradayrol, L., Pyronnet, S., Susini, C. (2003). sst2 Somatostatin receptor inhibits cell proliferation through Ras -, Rap1 -, and B-Raf-dependent ERK2 activation. J Biol Chem 278: 39356 - 39371.
92. Cattaneo, M.G., Scita, G., Vicentini, L.M. (1999). Somatostatin inhibits PDGF - stimulated Ras activation in human neuroblastoma cells. FEBS Lett 459: 64-68.
93. Dent, P., Wang, Y., Gu, Y.Z., Wood, S.L., Reardon, D.B., Mangues, R., Pellicer, A., Schonbrunn, A., Sturgill, T.W. (1997). S49 cells endogenously express subtype 2 somatostatin receptors which couple to increase protein tyrosine phosphatase activity in membranes and down-regulate Raf-1 activity in situ. Cell Signal 9: 539-549.
94. Douziech, N., Calvo, E., Coulombe, Z., Muradia, G., Bastien, J., Aubin, R.A., Lajas, A., Morisset, J. (1999). Inhibitory and stimulatory effects of somatostatin on two human pancreatic cancer cell lines: a primary role for tyrosine phosphatase SHP-1. Endocrinology 140: 765-777.
95. Florio, T., Arena, S., Thellung, S., Iuliano, R., Corsaro, A., Massa, A., Pattarozzi, A., Bajetto, A., Trapasso, F., Fusco, A., Schettini, G. (2001). The activation of the phosphotyrosine phosphatase eta (r-PTP eta). is responsible for the somatostatin inhibition of PC Cl3 thyroid cell proliferation. Mol Endocrinol 15: 1838-1852.
96. Florio, T., Morini, M., Villa, V., Arena, S., Corsaro, A., Thellung, S., Culler, M.D., Pfeffer, U., Noonan, D.M., Schettini, G., Albini, A. (2003a). Somatostatin inhibits tumor angiogenesis and growth via somatostatin receptor-3-mediated regulation of endothelial nitric oxide synthase and mitogen-activated protein kinase activities . Endocrinology 144: 1574-1584.
97. Cordelier, P., Esteve, J.P., Bousquet, C., Delesque, N., O'Carroll, A.M., Schally, A.V., Vaysse, N., Susini, C., Buscail, L. (1997). Characterization of the antiproliferative signal mediated by the somatostatin receptor subtype sst5. Proc Natl Acad Sci U S A 94: 9343-9348.
98. Smalley, K.S., Feniuk, W., Sellers, L.A., Humphrey, P.P. (1999). The pivotal role of phosphoinositide-3 kinase in the human somatostatin sst(4). receptor-mediated stimulation of p44/p42 mitogen-activated protein kinase and extracellular acidifi- cation. Biochem Biophys Res Commun 263: 239-243.
99. Sellers, L.A., Alderton, F., Carruthers, A.M., Schindler, M., Humphrey, P.P. (2000). Receptor isoforms mediate opposing proliferative effects through gbetagamma - activated p38 or Akt pathways. Mol Cell Biol 20: 5974-5985.
100. Williams, G., Ball, J., Bloom, S., Joplin, G.F. (1986). Improvement in headache associated with prolactinoma during treatment with a somatostatin analogue: an " N of 1" study. N Engl J Med 315: 1166-1167.
101. Mollenholt, P., Rawal, N., Gordh, T., Jr., Olsson, Y. (1994). Intrathecal and epidural somatostatin for patients with cancer. Analgesic effects and postmortem neuropathologic investigations of spinal cord and nerve roots. Anesthesiology 81: 534-542.
102. Penn, R.D., Paice, J.A., Kroin, J.S. (1992). Octreotide: a potent new non-opiate analgesic for intrathecal infusion. Pain 49 (1): 13-19.
103. Carlton, S.M., Du, J., Davidson, E., Zhou, S., Coggeshall, R.E. (2001). Somatostatin receptors on peripheral primary afferent terminals: inhibition of sensitized nociceptors . Pain 90: 233-244.
104. Gaumann, D.M., Yaksh, T.L., Post, C., Wilcox, G.L., Rodriguez, M. (1989). Intrathecal somatostatin in cat and mouse studies on pain, motor behavior, and histopathology. Anesth Analg 68 (5): 623-632.
105. Gaumann, D.M., Yaksh, T.L. (1988). Adrenal and intestinal secretion of catecholamines and neuropeptides during splanchnic artery occlusion shock. Circ Shock 26 (4): 391-407.
106. Bentoin, F., Ardid, D., Herbet, A., Aumaitre, O., Kemeny, J.L., Duchene-Marullaz, P., Lavarenne, J., Eschalier, A. (1994). Evidence for a central long-lasting antinociceptive effect of vapreotide, an analog of somatostatin, involving an opioidergic mechanism. J Pharmacol Exp Ther 269: 7-14.
107. Green, P.G., Basbaum, A.I., Levine, J.D. (1992). Sensory neuropeptide interactions in the production of plasma extravasation in the rat. Neuroscience 50: 745-749.
108. Pinter, E., Helyes, Z., Szolcsanyi, J. (2006). Inhibitory effect of somatostatin on inflammation and nociception. Pharmacol Ther 112: 440-456.
109. Polo-Parada, L., Pilar, G. (1999). Kappa-and mu-opioids reverse the somatostatin inhibition of Ca 2+ currents in ciliary and dorsal root ganglion neurons. J Neurosci 19: 5213-5227.
110. Scarborough, D.E., Lee, S.L., Dinarello, C.A., Reichlin, S. (1989). Interleukin 1 stimulates somatostatin biosynthesis in primary cultures of fetal rat brain. Endocrinology 124: 549-551.
111. Scarborough, D.E. (1990). Somatostatin regulation by cytokines. Metabolism 39: 108-111.
112. Rogers, K.V., Vician, L., Stein, R.A., Clifton, D.K. (1988). The effect of hypophysectomy and growth hormone administration on preprosomatostatin mRNA in the periventricular nucleus of the rat hypothalamus. Endocrinology 122: 586-591.
113. Zeytin, F.N., Rusk, S.F., De Lellis, R. (1988). Growth hormone releasing factor and fibroblast growth factor regulate somatostatin gene expression. Endocrinology 122: 1133-1136.
114. Lopez-Fernandez, J., Sanchez-Franco, F., Yelasco, B., Tolon, R.M., Pazos, F., Cacicedo, L. (1996). Growth hormone induces somatostatin and insulin like growth factor I gene expression in the cerebral hemispheres of aging rats. Endocrinology 137: 4384-439.
115. Saklatvala, J., Davis, W., Guesdon, F. (1996). Interleukin 1 (IL-1) and tumour necrosis factor (TNF) signal transduction. Philos Trans R Soc Lond B Biogr Sci 351: 151-157.
116. Pawlak, M., Schmidt, R.F. (2004). Octreotide, a somatostatin analogue, attenuates movement evoked discharges of fine afferent units from inflamed knee joints of rats. Neurosci Lett 361: 180-183.
117. Paran, D., Elkayam, O., Mayo, A., Paran, H., Amit, M., Yaron, M., Caspi, D. (2001). A pilot study of a long acting somatostatin analogue for the treatment of refractory rheumatoid arthritis. Ann Rheum Dis 60: 888-891.
118. Malcangio, M. (2003). GDNF and somatostatin in sensory neurones. Curr Opin Pharmacol 3: 41-45.
119. Kolasinski, S.L., Haines, K.A., Siegel, E.L., Cronstein, B.N., Abramson, S.B. (1992). Neuropeptides and inflammation. A somatostatin analog as a selective antagonist of neutrophil activation by substance P. Arthritis Rheum 35 (4): 369-375.
120. Fioravanti, A., Govoni, M., La Montagna, G., Perpignano, G., Tirri, G., Trotta, F., Bogliolo, A., Ciocci, A., Mauceri, M. T., Marcolongo, R. (1995). Somatostatin 14 and joint inflammation: evidence for intraarticular efficacy of prolonged administration in rheumatoid arthritis. Drugs Exp Clin Res 21: 97-103.
121. Matucci-Cerinic, M., Marabini, S. (1998). Somatostatin treatment for pain in rheumatoid arthritis: a double blind versus placebo study in knee involvement. Med Sci Res 16: 233-234.
122. Silveri, F., Morosini, P., Brecciaroli, D., Cervini, C. (1994). Intra-articular injection of somatostatin in knee osteoarthritis: clinical results and IGF-1 serum levels. Int J Clin Pharmacol Res 14 (2): 79-85.
123. Reichlin, S. (1993). Neuroendocrine-immune interaction. N Engl J Med 329: 1246-1253.
124. Fais, S., Annibale, B., Boirivant, M., Santoro, A., Pallone, F., Delle Fave, G. (1991). Effect of somatostatin on human intestinal lamina propria lymphocytes. Modulation of lymphocyte activation. J Neuroimmunol 31: 211-219.
125. Van Hagen, P.M., Markusse, H.M., Lamberts, S.W., Kwekkeboom, D.J., Reubi, J.C., Krenning, E.P. (1994). Somatostatin receptor imaging. The presence of somatostatin receptors in rheumatoid arthritis. Arthritis Rheum 37: 1521-1527.
126. Takeba, Y., Suzuki Ntakeno, M., Asai, T., Tsuboi, S., Hoshino, T., Sakane, T. (1997). Modulationn of sinovial cell function by somatostatin in patients with rheumatoid arthritis. Arthritis Rheum 40: 2128-2138.
127. Gonzalez-Ray, E., Chorny, A., Del Moral, R.G., Varela, N., Delgado, M. (2007). Therapeutic effect of cortistatin on experimental arthritis by downregulating inflammatory and Th1 response. Ann Rheum Dis 66: 582-588.